These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16235577)

  • 41. Health effects of garlic.
    Tattelman E
    Am Fam Physician; 2005 Jul; 72(1):103-6. PubMed ID: 16035690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complementary and alternative medicine research and cooperative groups: can it happen?
    O'Mara A
    J Pediatr Oncol Nurs; 2006; 23(5):258-60. PubMed ID: 16902079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Japan works to shorten "drug lag," boost trials of new drugs.
    Sinha G
    J Natl Cancer Inst; 2010 Feb; 102(3):148-51. PubMed ID: 20107160
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of the National Cancer Institute in drug development.
    Doroshow J
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
    [No Abstract]   [Full Text] [Related]  

  • 45. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ; Young DM; Davis RD; Cooney DA; Guarino AM
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract]   [Full Text] [Related]  

  • 46. FDA starts moving on critical path, but initiative running out of steam.
    Finkelstein JB
    J Natl Cancer Inst; 2007 Mar; 99(6):426-7. PubMed ID: 17374831
    [No Abstract]   [Full Text] [Related]  

  • 47. [Past and current problems in tumor research].
    von Wasielewski E; Sedlacek HH
    Dtsch Med Wochenschr; 1986 Apr; 111(16):630-7. PubMed ID: 3956405
    [No Abstract]   [Full Text] [Related]  

  • 48. Laetrile.
    N Engl J Med; 1982 Jul; 307(2):118-20. PubMed ID: 7045657
    [No Abstract]   [Full Text] [Related]  

  • 49. Developing strategies to link basic cardiovascular sciences with clinical drug development: another opportunity for translational sciences.
    Feldman AM; Koch WJ; Force TL
    Clin Pharmacol Ther; 2007 Jun; 81(6):887-92. PubMed ID: 17392727
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuing innovations for health.
    Shine KI
    FASEB J; 1997 May; 11(6):398-403. PubMed ID: 9194520
    [No Abstract]   [Full Text] [Related]  

  • 51. Cancer prevention research trials.
    Greenwald P; Malone WF; Cerny ME; Stern HR
    Adv Cancer Res; 1993; 61():1-23. PubMed ID: 8346716
    [No Abstract]   [Full Text] [Related]  

  • 52. Herbal administration and interaction of cancer treatment.
    Arslan D; Tural D; Akar E
    J Palliat Med; 2013 Nov; 16(11):1466-76. PubMed ID: 24102459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The National Cancer Chemotherapy Program.
    Frei E
    Science; 1982 Aug; 217(4560):600-6. PubMed ID: 7046055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-oriented research: definitions and new paradigms.
    Strom BL; Norman S; Margolis DJ
    Am J Med; 2000 Aug; 109(2):164-5. PubMed ID: 10967160
    [No Abstract]   [Full Text] [Related]  

  • 55. The NIH Methodology Conference: the methodology debate in the United Kingdom during the past ten years.
    Vickers A
    J Altern Complement Med; 1995; 1(2):209-12. PubMed ID: 9395615
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of antineoplastons A10 and AS2-1.
    Burzynski SR
    Mayo Clin Proc; 1999 Jun; 74(6):641-2. PubMed ID: 10377942
    [No Abstract]   [Full Text] [Related]  

  • 57. SIREN to Replace NETT and ROC.
    Berger E
    Ann Emerg Med; 2016 Feb; 67(2):22A-24A. PubMed ID: 27195339
    [No Abstract]   [Full Text] [Related]  

  • 58. Reader comments on complementary and alternative medicine articles.
    Lyttle T
    Oncol Nurs Forum; 2006 Jul; 33(4):684; author reply 684. PubMed ID: 16862656
    [No Abstract]   [Full Text] [Related]  

  • 59. Recent occurrences in the discovery and development of drugs to treat HIV infections.
    McGowan JJ
    Ann N Y Acad Sci; 1989; 569():231-9. PubMed ID: 2698091
    [No Abstract]   [Full Text] [Related]  

  • 60. Cross-trial comparisons in the oncology arena: when is this justified?
    Markman M
    Oncology; 2011; 80(3-4):151-2. PubMed ID: 21677463
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.